PCN99 Cost-Effectiveness of Dasatinib versus High-Dose Imatinib and Nilotinib in Patients with Chronic Myeloid Leukaemia Resistant to Standard-Dose Imatinib in Portugal
Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.1200
https://www.valueinhealthjournal.com/article/S1098-3015(11)02762-8/fulltext
Title :
PCN99 Cost-Effectiveness of Dasatinib versus High-Dose Imatinib and Nilotinib in Patients with Chronic Myeloid Leukaemia Resistant to Standard-Dose Imatinib in Portugal
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)02762-8&doi=10.1016/j.jval.2011.08.1200
First page :
A452
Section Title :
Cancer
Open access? :
No
Section Order :
1159